Half Year 2020 Basilea Pharmaceutica AG Earnings Call Transcript
Ladies and gentlemen, welcome to the Basilea Pharmaceutica 2020 Half Year Results and Publication of the Half Year Report 2020 Conference Call and live webcast. I am Alessandro, the Chorus Call operator. (Operator Instructions) The conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to David Veitch, Chief Executive Officer. Please go ahead, sir.
Thank you. Hello. This is David Veitch, CEO of Basilea. I would like to welcome you all for our conference call and webcast, reviewing our financial results and key achievements for the first half year 2020, and discussing our upcoming milestones and financial guidance for the remainder of the year. I would also like to mention that this call contains forward-looking statements.
Joining me on our call today are Adesh Kaul, our Chief Financial Officer and Dr. Marc Engelhardt, our Chief Medical
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |